# FDA Inspection 1292016 - Lelypharma BV - September 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/lelypharma-bv/c2b38759-d845-42cd-9ab2-10a20afe8a7c
Source feed: FDA_Inspections

> FDA Inspection 1292016 for Lelypharma BV on September 26, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1292016
- Company Name: Lelypharma BV
- Inspection Date: 2025-09-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/lelypharma-bv/64cfb6c8-9793-451a-95bf-c15863b1447c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c